Merger, Allocation of Purchase Price (Details) - USD ($) $ in Thousands |
12 Months Ended | ||||
---|---|---|---|---|---|
Nov. 05, 2020 |
Dec. 31, 2021 |
Dec. 31, 2020 |
|||
Allocation of Purchase Price [Abstract] | |||||
Cash acquired | $ 0 | $ 2,014 | |||
IPR&D | $ 0 | $ 10,502 | |||
Rexahn [Member] | |||||
Allocation of Purchase Price [Abstract] | |||||
Cash acquired | $ 2,014 | ||||
Net assets assumed | 68 | ||||
IPR&D | [1] | 8,376 | |||
Purchase price | $ 10,458 | ||||
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Amount of assets incurred by the acquirer as part of consideration transferred in a business combination. No definition available.
|
X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition. No definition available.
|
X | ||||||||||
- Details
|